Related references
Note: Only part of the references are listed.Avacopan: First Approval
Arnold Lee
DRUGS (2022)
Asciminib: First Approval
Emma D. Deeks
DRUGS (2022)
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
Fredrik H. Schjesvold et al.
LANCET HAEMATOLOGY (2022)
Fluorine-containing agrochemicals in the last decade and approaches for fluorine incorporation
Qiang Wang et al.
CHINESE CHEMICAL LETTERS (2022)
Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity
Yingjie Yu et al.
CHINESE CHEMICAL LETTERS (2021)
Belzutifan: First Approval
Emma D. Deeks
DRUGS (2021)
Recent Advances in Synthesis of Difluoromethylene Phosphonates for Biological Applications
Michael Shevchuk et al.
ADVANCED SYNTHESIS & CATALYSIS (2021)
B-Cell Lymphomas, Version 5.2021 Featured Updates to the NCCN Guidelines
Andrew D. Zelenetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
Nathan H. Fowler et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Avacopan - Time to Replace Glucocorticoids?
Kenneth J. Warrington
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Avacopan for the Treatment of ANCA-Associated Vasculitis
David R. W. Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event
Adnan Alsumali et al.
ADVANCES IN THERAPY (2021)
Chemical Aspects of Human and Environmental Overload with Fluorine
Jianlin Han et al.
CHEMICAL REVIEWS (2021)
Vericiguat: First Approval
Anthony Markham et al.
DRUGS (2021)
Melphalan Flufenamide (Melflufen): First Approval
Sohita Dhillon
DRUGS (2021)
Umbralisib: First Approval
Sohita Dhillon et al.
DRUGS (2021)
Recommended Tests for the Self-Disproportionation of Enantiomers (SDE) to Ensure Accurate Reporting of the Stereochemical Outcome of Enantioselective Reactions
Jianlin Han et al.
MOLECULES (2021)
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K. Choueiri et al.
NATURE MEDICINE (2021)
Sotorasib: First Approval
Hannah A. Blair
DRUGS (2021)
Asciminib: an investigational agent for the treatment of chronic myeloid leukemia
Massimo Breccia et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
A Call for a Change in Policy Regarding the Necessity for SDE Tests to Validate the Veracity of the Outcome of Enantioselective Syntheses, the Inherent Chiral State of Natural Products, and Other Cases Involving Enantioenriched Samples
Jianlin Han et al.
MOLECULES (2021)
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
Fortunato Morabito et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Applications of fluorine-containing amino acids for drug design
Haibo Mei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Reagents for Selective Fluoromethylation: A Challenge in Organofluorine Chemistry
Marco Reichel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
Brian A. Lanman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Tailor-Made Amino Acids and Fluorinated Motifs as Prominent Traits in Modern Pharmaceuticals
Haibo Mei et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Fluorine-containing drugs approved by the FDA in 2019
Haibo Mei et al.
CHINESE CHEMICAL LETTERS (2020)
Metabolism and Pharmacokinetic Drug-Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies
Michael Boettcher et al.
CLINICAL PHARMACOKINETICS (2020)
Cabotegravir Plus Rilpivirine: First Approval
A. Markham
DRUGS (2020)
KRAS(G12C)-AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations
Tatu Pantsar
SCIENTIFIC REPORTS (2020)
Current Contributions of Organofluorine Compounds to the Agrochemical Industry
Yuta Ogawa et al.
ISCIENCE (2020)
Next generation organofluorine containing blockbuster drugs
Jianlin Han et al.
JOURNAL OF FLUORINE CHEMISTRY (2020)
Advances in Organofluorine Compounds with Aggregation-Induced Emission
Chengyuan Qin et al.
CHINESE JOURNAL OF ORGANIC CHEMISTRY (2020)
Review of Synthetic Routes and Final Forms of Integrase Inhibitors Dolutegravir, Cabotegravir, and Bictegravir
David L. Hughes
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
Fluorine-Containing Drugs Approved by the FDA in 2018
Haibo Mei et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
Development of a Safe Process for Manufacturing of the Potent Anticancer Agent Melflufen Hydrochloride
Hanna Cotton et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
Rui Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
T. P. Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Fluorescent chemodosimeters for fluoride ions via silicon-fluorine chemistry: 20 years of progress
Pengpeng Chen et al.
JOURNAL OF MATERIALS CHEMISTRY C (2019)
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
Tian Zhou et al.
BIOMATERIALS (2018)
Modern Approaches for Asymmetric Construction of Carbon-Fluorine Quaternary Stereogenic Centers: Synthetic Challenges and Pharmaceutical Needs
Yi Zhu et al.
CHEMICAL REVIEWS (2018)
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study
Howard A. Burris et al.
LANCET ONCOLOGY (2018)
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
Joseph Schoepfer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)
Paul M. Wehn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Recent Advance in Asymmetric Trifluoromethylthiolation
Li Shu-Sen et al.
ACTA CHIMICA SINICA (2018)
Strategic incorporation of fluorine into taxoid anticancer agents for medicinal chemistry and chemical biology studies
Iwao Ojima
JOURNAL OF FLUORINE CHEMISTRY (2017)
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
Markus Follmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David R. W. Jayne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
David A. Margolis et al.
LANCET (2017)
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1
Andrew A. Wylie et al.
NATURE (2017)
Melflufen - a peptidase-potentiated alkylating agent in clinical trials
Malin Wickstrom et al.
ONCOTARGET (2017)
Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1
Said A. Hassounah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Eli M. Wallace et al.
CANCER RESEARCH (2016)
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
Yu Zhou et al.
CHEMICAL REVIEWS (2016)
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen et al.
NATURE (2016)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2
Thomas H. Scheuerrnann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor
Huan Wang et al.
ORGANIC LETTERS (2015)
Formulation and pharmacology of long-acting cabotegravir
Christine Trezza et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Advances in Catalytic Enantioselective Fluorination, Mono-, Di-, and Trifluoromethylation, and Trifluoromethylthiolation Reactions
Xiaoyu Yang et al.
CHEMICAL REVIEWS (2015)
Synthetic Methods for Compounds Having CF3-S Units on Carbon by Trifluoromethylation, Trifluoromethylthiolation, Triflylation, and Related Reactions
Xiu-Hua Xu et al.
CHEMICAL REVIEWS (2015)
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011)
Jiang Wang et al.
CHEMICAL REVIEWS (2014)
Addition of CF3 across unsaturated moieties: a powerful functionalization tool
Estibaliz Merino et al.
CHEMICAL SOCIETY REVIEWS (2014)
Successful fluorine-containing herbicide agrochemicals
Tomoya Fujiwara et al.
JOURNAL OF FLUORINE CHEMISTRY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Optical Purifications via Self-Disproportionation of Enantiomers by Achiral Chromatography: Case Study of a Series of-CF3-containing Secondary Alcohols
Alexander E. Sorochinsky et al.
CHIRALITY (2013)
Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor
Mamta Sharma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor
Jamie L. Rogers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)
Brian A. Johns et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Allosteric inhibition of hypoxia inducible factor-2 with small molecules
Thomas H. Scheuermann et al.
NATURE CHEMICAL BIOLOGY (2013)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
Reaction of Iodonium Ylides of 1,3-Dicarbonyl Compounds with HF Reagents
Keisuke Gondo et al.
MOLECULES (2012)
Asymmetric synthesis of phosphonotrifluoroalanine and its derivatives using N-tert-butanesulfinyl imine derived from fluoral
Gerd-Volker Roeschenthaler et al.
TETRAHEDRON LETTERS (2012)
Biomimetic Transamination - a Metal-Free Alternative to the Reductive Amination. Application for Generalized Preparation of Fluorine-Containing Amines and Amino Acids
Jianlin Han et al.
CURRENT ORGANIC SYNTHESIS (2011)
Self-Disproportionation of Enantiomers via Sublimation; New and Truly Green Dimension in Optical Purification
Jianlin Han et al.
CURRENT ORGANIC SYNTHESIS (2011)
Electrophilic trifluoromethylation of arenes and N-heteroarenes using hypervalent iodine reagents
Matthias S. Wiehn et al.
JOURNAL OF FLUORINE CHEMISTRY (2010)
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang et al.
NATURE (2010)
Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity
Xiao-Qing Feng et al.
CHEMMEDCHEM (2009)
Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Thomas H. Scheuermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fluorine in medicinal chemistry
Sophie Purser et al.
CHEMICAL SOCIETY REVIEWS (2008)
Strategies for nucleophilic, electrophilic, and radical trifluoromethylations
Jun-An Ma et al.
JOURNAL OF FLUORINE CHEMISTRY (2007)
Fluorine in medicinal chemistry: A review of anti-cancer agents
C Isanbor et al.
JOURNAL OF FLUORINE CHEMISTRY (2006)
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients
JL Bellamy et al.
HEADACHE (2006)
Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1
J Guillemont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
BIBN4096BS antagonizes human α-calcitonin gene related peptide-induced headache and extracerebral artery dilatation
KA Petersen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Selective fluorination of an aryl triazolinone herbicide intermediate
RG Syvret et al.
JOURNAL OF FLUORINE CHEMISTRY (2004)
Chemo- and regioselectivity in the reactions between highly electrophilic fluorine containing dicarbonyl compounds and amines. Improved synthesis of the corresponding imines/enamines
H Ohkura et al.
TETRAHEDRON (2003)
Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives
J Gullbo et al.
ONCOLOGY RESEARCH (2003)
Identification of a potent and orally active non-peptide C5a receptor antagonist
H Sumichika et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Novel process for generating useful electrophiles from common anions using Selectfluor® fluorination agent
RG Syvret et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Intractable eye pain: indication for triptans
A May et al.
CEPHALALGIA (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice
AM Salmon et al.
NATURE NEUROSCIENCE (2001)
Plasma levels of calcitonin gene-related peptide in chronic tension-type headache
M Ashina et al.
NEUROLOGY (2000)
A new small molecule C5a receptor antagonist inhibits the reverse-passive arthus reaction and endotoxic shock in rats
AJ Strachan et al.
JOURNAL OF IMMUNOLOGY (2000)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
